Literature DB >> 10980351

Surgical experience of the thoracic aortic aneurysm due to Takayasu's arteritis.

S Sasaki1, S Kubota, T Kunihara, N Shiiya, K Yasuda.   

Abstract

We have treated 10 patients with thoracic aortic aneurysms due to Takayasu's arteritis during the last 15 years and presented surgical results. In the surgical treatment of thoracic aortic aneurysm due to Takayasu's arteritis, therapeutic strategy is different from that for atherosclerotic aneurysm and should be determined by the location and the extent of aneurysmal lesions and the degree of inflammation. Palliative procedure, which was taken to reduce surgical risk, has failed to prevent the recurrence of aneurysmal formation or to minimize surgical risk in the later period. Radical surgical treatment for thoracic aortic aneurysms is highly recommended if technically possible. Penoperative steroid therapy to control the degree of inflammation, appropriate strategy for multiple or extensive lesions and progress in the organ protection method that enabled radical treatment, all these will contribute to the improvement of surgical results.

Entities:  

Mesh:

Year:  2000        PMID: 10980351     DOI: 10.1016/s0167-5273(00)00183-2

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

Review 1.  Takayasu arteritis: a review.

Authors:  S L Johnston; R J Lock; M M Gompels
Journal:  J Clin Pathol       Date:  2002-07       Impact factor: 3.411

Review 2.  Takayasu's arteritis.

Authors:  Antonio Fraga; Francisco Medina
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

3.  Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis.

Authors:  Ana F Águeda; Sara Monti; Raashid Ahmed Luqmani; Frank Buttgereit; Maria Cid; Bhaskar Dasgupta; Christian Dejaco; Alfred Mahr; Cristina Ponte; Carlo Salvarani; Wolfgang Schmidt; Bernhard Hellmich
Journal:  RMD Open       Date:  2019-09-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.